Channel 1 ESMO Colloquium

ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment

Date
22.09.2020
Time
13:00 - 14:30
Room
Channel 1
Chairs
  • Alexander Drilon (New York, NY, United States of America)
  • Giuseppe Curigliano (Milan, Italy)
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment ESMO Colloquium

Introduction

Lecture Time
13:00 - 13:05
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Session Name
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment ESMO Colloquium

Introduction to RET mutations and fusions and their incidence for potential use as target in cancer treatment

Lecture Time
13:05 - 13:20
Speakers
  • Alexander Drilon (New York, NY, United States of America)
Session Name
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment ESMO Colloquium

RET fusion TKI: Present results and recent developments in Lung cancer

Lecture Time
13:20 - 13:35
Speakers
  • David Planchard (Villejuif, France)
Session Name
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment ESMO Colloquium

RET alterations in Thyroid carcinomas: Results and recent update

Lecture Time
13:35 - 13:50
Speakers
  • Lori J. Wirth (Boston, MA, United States of America)
Session Name
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment ESMO Colloquium

RET determination: Present recommendation of the ESMO Precision Medicine working group

Lecture Time
13:50 - 14:05
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Session Name
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment ESMO Colloquium

Conclusion: Is RET targeting ready for an agnostic use?

Lecture Time
14:05 - 14:10
Speakers
  • Alexander Drilon (New York, NY, United States of America)
Session Name
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment ESMO Colloquium

Live Q&A

Lecture Time
14:10 - 14:30
Speakers
  • Giuseppe Curigliano (Milan, Italy)
  • Alexander Drilon (New York, NY, United States of America)
Session Name
ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment
Room
Channel 1
Date
22.09.2020
Time
13:00 - 14:30